These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17287074)

  • 1. Nephron-sparing surgery in renal cell carcinoma: did we sacrifice too many kidneys in the past?
    Fornara P
    Eur Urol; 2007 Jun; 51(6):1475-6. PubMed ID: 17287074
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor size and nephron-sparing surgery: does it still matter?
    Bensalah K; Crépel M; Patard JJ
    Eur Urol; 2008 Apr; 53(4):691-3. PubMed ID: 18060683
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein.
    Kolla SB; Ercole C; Spiess PE; Pow-Sang JM; Sexton WJ
    BJU Int; 2010 Nov; 106(10):1494-8. PubMed ID: 20230378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 10. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
    Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma.
    Berdjis N; Hakenberg OW; Zastrow S; Oehlschläger S; Novotny V; Wirth MP
    BJU Int; 2006 Jun; 97(6):1208-10. PubMed ID: 16686712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the staging of renal cell carcinoma.
    Leung AC; Ghavamian R
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):673-80. PubMed ID: 12503213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for total nephrectomy for suspected renal cell carcinoma.
    Marsh CL; Lange PH
    Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephron sparing surgery for renal cell carcinoma.
    Abu Ghazaleh LA; Shunaigat AN
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):557-60. PubMed ID: 21566321
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations.
    Roos FC; Thomas C; Hampel C; Thüroff JW
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):805-8. PubMed ID: 21707272
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
    Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
    Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors?
    Terrone C; Volpe A
    Eur Urol; 2011 Apr; 59(4):553-5. PubMed ID: 21239104
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.